CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- 4 Planned sale Chief Financial Officer sold 30,385 shares at an average $18.21 ($553,198)
- 4 Planned sale President and COO sold 50,500 shares at an average $18.06 ($911,842)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-3 Offering Registration Statement
- 4 Planned sale Chief Legal Officer sold 33,807 shares at $14.75 ($498,653)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 15,829 shares at $11.49 ($181,875)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Legal Officer sold 15,829 shares at $10.43 ($165,096)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
Page 9 of 14 · 266 filings